Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2019

01-12-2019 | Hepatocellular Carcinoma | ASO Author Reflections

ASO Author Reflections: HCC in LIRADS Lesions—Neither the Exception nor the Rule

Authors: Ephraim Shin-Tian Tang, MD, MSc, FRCSC, Sulaiman Nanji, MD, PhD, FRCSC

Published in: Annals of Surgical Oncology | Special Issue 3/2019

Login to get access

Excerpt

While the Liver Imaging Reporting and Data System (LIRADS) classification scheme has gained widespread acceptance, the cumulative incidence of hepatocellular carcinoma (HCC) within each diagnostic category remains poorly defined, and the ACR has called for further studies to define the frequencies within these populations.1 As a result, there is considerable uncertainty related to the management of indeterminate observations, especially with LIRADS 3 and 4 observations. To this end, we sought to quantify the cumulative frequency of HCCs within high and intermediate LIRADS categories in as unbiased a fashion as possible. …
Literature
1.
Mitchell DG, Bruix J, Sherman M, Sirlin CB. LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology. 2015;61(3):1056–65.CrossRef
2.
Tang EST, Hall G, Yu D, et al. Predictors and cumulative frequency of hepatocellular carcinoma in high and intermediate LI-RADS lesions: a cohort study from a Canadian academic institution. Ann Surg Oncol. 2019;26:2560–7.CrossRef
3.
Yasaka K, Akai H, Abe O, Kiryu S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study. Radiology. 2018;286(3):887–96.CrossRef
4.
Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70:1133–44.CrossRef
Metadata
Title
ASO Author Reflections: HCC in LIRADS Lesions—Neither the Exception nor the Rule
Authors
Ephraim Shin-Tian Tang, MD, MSc, FRCSC
Sulaiman Nanji, MD, PhD, FRCSC
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07896-6

Other articles of this Special Issue 3/2019

Annals of Surgical Oncology 3/2019 Go to the issue

Correction

Correction to: Peritoneal Metastases in Colorectal Cancer

ASO Author Reflections

ASO Author Reflections: Intraoperative Fluid Restriction During CRS-HIPEC—Less is More

ASO Author Reflections

ASO Author Reflections: The BREAST-Q BCT Module and Its Use in Clinical Practice

ASO Author Reflections

ASO Author Reflections: Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma

ASO Author Reflections

ASO Author Reflections: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients

ASO Author Reflections

ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma